Title | Type | SJR | H index | Total Docs. (1999) | Total Docs. (3years) | Total Refs. (1999) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (1999) | %Female (1999) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Trends in Pharmacological Sciences | journal | 4.514 Q1 | 244 | 102 | 304 | 4699 | 2317 | 233 | 8.20 | 46.07 | 16.49 | |
2 | Reviews of Physiology Biochemistry and Pharmacology | journal | 3.271 Q1 | 70 | 31 | 22 | 5954 | 143 | 22 | 8.20 | 192.06 | 30.88 | |
3 | Neuropsychopharmacology | journal | 2.634 Q1 | 249 | 176 | 309 | 8662 | 1624 | 291 | 4.69 | 49.22 | 32.57 | |
4 | Neuropharmacology | journal | 2.249 Q1 | 191 | 182 | 563 | 8527 | 2242 | 556 | 4.05 | 46.85 | 27.40 | |
5 | Cellular and Molecular Life Sciences | journal | 1.724 Q1 | 261 | 227 | 449 | 21816 | 1104 | 447 | 2.92 | 96.11 | 28.18 | |
6 | Psychopharmacology | journal | 1.687 Q1 | 214 | 393 | 936 | 16557 | 3330 | 907 | 3.02 | 42.13 | 31.14 | |
7 | Clinical Pharmacokinetics | journal | 1.586 Q1 | 184 | 81 | 186 | 5697 | 1014 | 178 | 5.21 | 70.33 | 23.53 | |
8 | Current Opinion in Drug Discovery and Development | journal | 1.523 Q1 | 85 | 68 | 15 | 3096 | 67 | 15 | 4.47 | 45.53 | 13.75 | |
9 | Controlled Clinical Trials | journal | 1.339 Q1 | 76 | 48 | 169 | 1042 | 292 | 151 | 1.34 | 21.71 | 39.18 | |
10 | Receptors and Channels | journal | 1.182 Q1 | 44 | 21 | 78 | 923 | 148 | 78 | 1.65 | 43.95 | 19.40 | |
11 | Journal of Antimicrobial Chemotherapy | journal | 1.111 Q1 | 221 | 368 | 1077 | 7250 | 2914 | 842 | 2.71 | 19.70 | 32.50 | |
12 | Drug Discovery Today | journal | 0.973 Q1 | 215 | 220 | 303 | 4732 | 576 | 285 | 1.54 | 21.51 | 23.73 | |
13 | Naunyn-Schmiedeberg's Archives of Pharmacology | journal | 0.956 Q1 | 99 | 166 | 606 | 5842 | 1323 | 605 | 2.03 | 35.19 | 29.42 | |
14 | European Journal of Pharmacology | journal | 0.953 Q1 | 203 | 908 | 2899 | 32018 | 6281 | 2899 | 2.05 | 35.26 | 28.49 | |
15 | Journal of Psychopharmacology | journal | 0.948 Q1 | 135 | 83 | 210 | 2474 | 450 | 200 | 2.65 | 29.81 | 24.84 | |
16 | Planta Medica | journal | 0.912 Q1 | 135 | 240 | 613 | 3855 | 745 | 566 | 1.15 | 16.06 | 33.41 | |
17 | Drug and Alcohol Dependence | journal | 0.888 Q1 | 187 | 109 | 321 | 4438 | 656 | 316 | 2.09 | 40.72 | 37.99 | |
18 | Chemical Biology and Drug Design | journal | 0.862 | 91 | 143 | 244 | 4445 | 416 | 242 | 1.70 | 31.08 | 29.30 | |
19 | Journal of Antibiotics | journal | 0.858 Q1 | 92 | 163 | 619 | 2320 | 682 | 573 | 1.07 | 14.23 | 23.49 | |
20 | British Journal of Clinical Pharmacology | journal | 0.827 Q1 | 167 | 237 | 645 | 6020 | 1458 | 596 | 2.34 | 25.40 | 26.36 | |
21 | Drug Safety | journal | 0.795 Q1 | 140 | 92 | 208 | 6358 | 598 | 202 | 2.83 | 69.11 | 29.67 | |
22 | Cancer Chemotherapy and Pharmacology, Supplement | journal | 0.794 Q1 | 35 | 17 | 61 | 623 | 140 | 59 | 2.51 | 36.65 | 18.52 | |
23 | European Neuropsychopharmacology | journal | 0.753 Q1 | 130 | 113 | 259 | 3632 | 462 | 256 | 2.88 | 32.14 | 25.10 | |
24 | Investigational New Drugs | journal | 0.720 Q1 | 97 | 38 | 143 | 2490 | 301 | 142 | 2.01 | 65.53 | 23.08 | |
25 | Journal of Lipid Mediators and Cell Signalling | journal | 0.717 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
26 | Antiviral Research | journal | 0.703 Q1 | 151 | 70 | 217 | 3183 | 441 | 216 | 1.98 | 45.47 | 27.76 | |
27 | Apoptosis : an international journal on programmed cell death | journal | 0.700 Q1 | 128 | 48 | 130 | 2463 | 202 | 130 | 1.44 | 51.31 | 36.31 | |
28 | Cytokines, Cellular and Molecular Therapy | journal | 0.670 Q1 | 28 | 26 | 56 | 1337 | 101 | 55 | 1.80 | 51.42 | 34.78 | |
29 | Perspectives in Drug Discovery and Design | journal | 0.664 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
30 | Tumor Targeting | journal | 0.664 Q1 | 10 | 32 | 22 | 1183 | 41 | 21 | 1.86 | 36.97 | 31.07 | |
31 | Progress in Medicinal Chemistry | journal | 0.657 Q1 | 38 | 7 | 20 | 1411 | 37 | 12 | 1.25 | 201.57 | 6.67 | |
32 | Cancer Chemotherapy and Pharmacology | journal | 0.636 Q2 | 122 | 163 | 470 | 4403 | 841 | 466 | 1.78 | 27.01 | 28.93 | |
33 | Journal of Veterinary Pharmacology and Therapeutics | journal | 0.624 Q2 | 67 | 55 | 234 | 1416 | 223 | 233 | 0.81 | 25.75 | 22.79 | |
34 | European Journal of Clinical Pharmacology | journal | 0.595 Q2 | 123 | 137 | 550 | 3310 | 923 | 510 | 1.63 | 24.16 | 30.00 | |
35 | Biomedical Chromatography | journal | 0.593 Q2 | 71 | 126 | 252 | 2064 | 265 | 250 | 0.96 | 16.38 | 33.12 | |
36 | Clinical and Experimental Pharmacology and Physiology | journal | 0.580 Q2 | 115 | 209 | 626 | 7197 | 887 | 625 | 1.27 | 34.44 | 24.29 | |
37 | Immunopharmacology | journal | 0.565 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
38 | Modern Trends in Pharmacopsychiatry | journal | 0.535 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
39 | Inflammation Research | journal | 0.534 Q2 | 107 | 169 | 455 | 4310 | 642 | 449 | 1.33 | 25.50 | 29.06 | |
40 | Xenobiotica | journal | 0.534 Q2 | 89 | 93 | 297 | 3240 | 478 | 296 | 1.42 | 34.84 | 21.82 | |
41 | PharmacoEconomics | journal | 0.533 Q2 | 118 | 134 | 438 | 5226 | 626 | 403 | 1.41 | 39.00 | 29.15 | |
42 | Cardiovascular Drugs and Therapy | journal | 0.530 Q2 | 79 | 58 | 286 | 1868 | 335 | 255 | 1.02 | 32.21 | 16.07 | |
43 | Journal of Peptide Science | journal | 0.517 Q2 | 73 | 58 | 128 | 2119 | 150 | 128 | 1.26 | 36.53 | 30.89 | |
44 | European Journal of Medicinal Chemistry | journal | 0.515 Q2 | 203 | 107 | 306 | 3103 | 398 | 297 | 1.17 | 29.00 | 33.07 | |
45 | Journal of Food Biochemistry | journal | 0.513 Q2 | 64 | 38 | 83 | 1154 | 61 | 83 | 0.69 | 30.37 | 38.24 | |
46 | Antiviral Chemistry and Chemotherapy | journal | 0.497 Q2 | 59 | 32 | 176 | 1616 | 306 | 175 | 1.79 | 50.50 | 24.03 | |
47 | Cytokines and Molecular Therapy | journal | 0.490 Q2 | 14 | 0 | 31 | 0 | 49 | 31 | 0.00 | 0.00 | 0.00 | |
48 | Phytomedicine | journal | 0.461 Q2 | 141 | 58 | 156 | 1070 | 143 | 156 | 0.70 | 18.45 | 36.25 | |
49 | Fitoterapia | journal | 0.455 Q2 | 124 | 143 | 392 | 1503 | 151 | 392 | 0.35 | 10.51 | 35.66 | |
50 | Autonomic and Autacoid Pharmacology | journal | 0.452 Q2 | 24 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®